Advocacy at a Glance STEVEN GROSSMAN 7/31/15 Advocacy at a Glance STEVEN GROSSMAN 7/31/15 Not the Scenario We Had Hoped For Read More Advocacy at a Glance STEVEN GROSSMAN 7/31/15 Advocacy at a Glance STEVEN GROSSMAN 7/31/15 Science Board Issues Latest Report on FDA and Regulatory Science and more Read More Analysis and Commentary STEVEN GROSSMAN 7/24/15 Analysis and Commentary STEVEN GROSSMAN 7/24/15 Time's-a-Passing: Good, Bad, or Something in the Middle? Read More Advocacy at a Glance STEVEN GROSSMAN 7/24/15 Advocacy at a Glance STEVEN GROSSMAN 7/24/15 Appropriations End-Game Being Discussed and more Read More Analysis and Commentary STEVEN GROSSMAN 7/17/15 Analysis and Commentary STEVEN GROSSMAN 7/17/15 Initial Break-Out of Senate Ag/FDA Committee FY 16 Appropriation Read More Advocacy at a Glance STEVEN GROSSMAN 7/17/15 Advocacy at a Glance STEVEN GROSSMAN 7/17/15 New FDA Report on Targeted Drug Development and more Read More Uncategorized STEVEN GROSSMAN 7/15/15 Uncategorized STEVEN GROSSMAN 7/15/15 Senate Ag/FDA Subcommittee Marks Up FY 16 Appropriation Bill Read More Analysis and Commentary STEVEN GROSSMAN 7/10/15 Analysis and Commentary STEVEN GROSSMAN 7/10/15 Interpreting the Mood of the House on FDA Appropriations Read More Advocacy at a Glance STEVEN GROSSMAN 7/10/15 Advocacy at a Glance STEVEN GROSSMAN 7/10/15 Appropriations Scorecard: Bills on the Move and more Read More
Advocacy at a Glance STEVEN GROSSMAN 7/31/15 Advocacy at a Glance STEVEN GROSSMAN 7/31/15 Not the Scenario We Had Hoped For Read More
Advocacy at a Glance STEVEN GROSSMAN 7/31/15 Advocacy at a Glance STEVEN GROSSMAN 7/31/15 Science Board Issues Latest Report on FDA and Regulatory Science and more Read More
Analysis and Commentary STEVEN GROSSMAN 7/24/15 Analysis and Commentary STEVEN GROSSMAN 7/24/15 Time's-a-Passing: Good, Bad, or Something in the Middle? Read More
Advocacy at a Glance STEVEN GROSSMAN 7/24/15 Advocacy at a Glance STEVEN GROSSMAN 7/24/15 Appropriations End-Game Being Discussed and more Read More
Analysis and Commentary STEVEN GROSSMAN 7/17/15 Analysis and Commentary STEVEN GROSSMAN 7/17/15 Initial Break-Out of Senate Ag/FDA Committee FY 16 Appropriation Read More
Advocacy at a Glance STEVEN GROSSMAN 7/17/15 Advocacy at a Glance STEVEN GROSSMAN 7/17/15 New FDA Report on Targeted Drug Development and more Read More
Uncategorized STEVEN GROSSMAN 7/15/15 Uncategorized STEVEN GROSSMAN 7/15/15 Senate Ag/FDA Subcommittee Marks Up FY 16 Appropriation Bill Read More
Analysis and Commentary STEVEN GROSSMAN 7/10/15 Analysis and Commentary STEVEN GROSSMAN 7/10/15 Interpreting the Mood of the House on FDA Appropriations Read More
Advocacy at a Glance STEVEN GROSSMAN 7/10/15 Advocacy at a Glance STEVEN GROSSMAN 7/10/15 Appropriations Scorecard: Bills on the Move and more Read More
